Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04101851Not ApplicableActive Not Recruiting

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

Role: collaborator

NCT07422870Not Yet Recruiting

GRAnulomatous MAstitis REGistry Study

Role: lead

NCT05559411Recruiting

MEthods for LOcalization of Different Types of Breast Lesions

Role: lead

NCT04373655Recruiting

AXillary Surgery After NeoAdjuvant Treatment

Role: lead

All 4 trials loaded